Skip to main content
VCbacked
Log inGet Started

Bastion Therapeutics

London, United Kingdom

Bastion Therapeutics is a preclinical stage biotechnology startup that uses proprietary platform technology to boost Them for immune system.

$840K raised
Sep 2023
Venture - Series Unknown
Biotechnology

Top Investors

Pioneer GroupWren CapitalNG Bio

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bastion Therapeutics

How much funding has Bastion Therapeutics raised?
Bastion Therapeutics has raised $840K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
Who are Bastion Therapeutics's investors?
Bastion Therapeutics's investors include Pioneer Group, Wren Capital, NG Bio.
Where is Bastion Therapeutics headquartered?
Bastion Therapeutics is headquartered in London, United Kingdom.
What does Bastion Therapeutics do?
Bastion Therapeutics is a preclinical stage biotechnology startup that uses proprietary platform technology to boost Them for immune system.
What stage is Bastion Therapeutics at?
Bastion Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Bastion Therapeutics — Funding & Investors." VCBacked, September 12, 2023, https://www.vcbacked.co/company/bastion-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2023). Bastion Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bastion-therapeutics
Wikipedia (cite web)
{{cite web |title=Bastion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bastion-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K